Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 15, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8⁺ T Cell Responses

Published on: May 6, 2019

Evaluating CD8⁺ T cell responses in vitro.

François A Lemonnier¹

¹Unite "Immunite Cellulaire Antivirale", Institut Pasteur, Paris, France. francois.lemonnier@inserm.fr.

Methods in Molecular Biology (Clifton, N.J.)

|January 19, 2013

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characterisation of the HLA-DQ alpha eplet 52SK targeting the DQA1*01 alleles family.

HLA·2024

Same author

Separating the Wheat from the Chaff among HLA-DQ Eplets.

Journal of immunology (Baltimore, Md. : 1950)·2024

Same author

Evaluating CD8<sup>+</sup> T Cell Responses In Vitro.

Methods in molecular biology (Clifton, N.J.)·2019

Same author

Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein.

PLoS neglected tropical diseases·2017

Same author

The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.

Molecular & cellular proteomics : MCP·2015

Same author

Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.

Journal of immunology (Baltimore, Md. : 1950)·2014

Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Methods for Functional Validation of Terpenoid Metabolic Clusters in Nicotiana benthamiana and Aspergillus oryzae.

Methods in molecular biology (Clifton, N.J.)·2026

See all related articles

The chromium-51 (51Cr) release assay, a long-standing gold standard for measuring cell killing, is being replaced by newer, nonradioactive tests for analyzing CD8(+) T cell responses.

Area of Science:

Immunology
Cellular Biology
Assay Development

Background:

The chromium-51 (51Cr) release assay has been the standard for decades to measure cell-mediated cytotoxicity.
Despite the development of other radioactive assays, the 51Cr assay remained dominant.
Advancements in understanding cytotoxic T lymphocyte (CTL) biology have driven the need for improved assays.

Purpose of the Study:

To review the historical significance and current limitations of the 51Cr release assay.
To highlight the emergence and advantages of nonradioactive assays for T cell response analysis.
To predict the future landscape of cytolytic assays in immunological research.

Main Methods:

Review of historical and contemporary immunological assay methodologies.

More Related Videos

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

In Vitro Resident Memory CD8 T Cell Differentiation Using Epithelial Organoid-T Cell Co-culture System

In Vitro Resident Memory CD8 T Cell Differentiation Using Epithelial Organoid-T Cell Co-culture System

Published on: February 3, 2026

Related Experiment Videos

Last Updated: May 15, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8⁺ T Cell Responses

Published on: May 6, 2019

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

In Vitro Resident Memory CD8 T Cell Differentiation Using Epithelial Organoid-T Cell Co-culture System

In Vitro Resident Memory CD8 T Cell Differentiation Using Epithelial Organoid-T Cell Co-culture System

Published on: February 3, 2026

Comparative analysis of radioactive (51Cr release) and nonradioactive assay performance.

Discussion of cytotoxic T lymphocyte (CTL) killing pathways and their detection.

Main Results:

The 51Cr release assay, established in the 1960s, has been the benchmark cytolytic assay for many years.
Nonradioactive assays have been developed based on a deeper understanding of CTL biology and killing mechanisms.
These novel nonradioactive methods show promise in supplanting the 51Cr release assay in the near future.

Conclusions:

The 51Cr release assay, while historically important, is facing obsolescence.
Newer nonradioactive assays offer reliable alternatives for assessing CD8(+) T cell responses.
The field is transitioning towards more advanced, nonradioactive methods for cytotoxicity assessment.